PURPOSE: This study tested possible neuroprotective effects of Camellia sinensis-extracted polyphenols in experimental hydrocephalus in young rats. METHODS: Seven-day-old Wistar rats were used in this study. Pups were subjected to hydrocephalus induction by 20 % kaolin intracisternal injection. The polyphenol was administered intraperitoneally for 9 or 20 days from the induction of hydrocephalus. Clinical observations and behavioral tests were performed once a day. The animals, deeply anesthetized, were sacrificed by cardiac perfusion with saline 10 or 21 days after induction of hydrocephalus and their brains were removed. Preparations were made for histological analysis by hematoxylin and eosin, solochrome-cyanine, and immunohistochemistry for GFAP. RESULTS: Histopathological analysis showed that animals treated with the polyphenol for 9 consecutive days displayed reduction on astrocyte activity on the corpus callosum and external capsule, shown by GFAP immunostaining. They also displayed thicker and myelinated corpus callosum, exhibiting a more intense solochrome-cyanine blue staining. CONCLUSION: Although these results demonstrate a possible neuroprotective effect at the initial onset of the disease, additional studies should be performed to obtain an effective and safe therapy for deeper studies in clinical trials.
PURPOSE: This study tested possible neuroprotective effects of Camellia sinensis-extracted polyphenols in experimental hydrocephalus in young rats. METHODS: Seven-day-old Wistar rats were used in this study. Pups were subjected to hydrocephalus induction by 20 % kaolin intracisternal injection. The polyphenol was administered intraperitoneally for 9 or 20 days from the induction of hydrocephalus. Clinical observations and behavioral tests were performed once a day. The animals, deeply anesthetized, were sacrificed by cardiac perfusion with saline 10 or 21 days after induction of hydrocephalus and their brains were removed. Preparations were made for histological analysis by hematoxylin and eosin, solochrome-cyanine, and immunohistochemistry for GFAP. RESULTS: Histopathological analysis showed that animals treated with the polyphenol for 9 consecutive days displayed reduction on astrocyte activity on the corpus callosum and external capsule, shown by GFAP immunostaining. They also displayed thicker and myelinated corpus callosum, exhibiting a more intense solochrome-cyanine blue staining. CONCLUSION: Although these results demonstrate a possible neuroprotective effect at the initial onset of the disease, additional studies should be performed to obtain an effective and safe therapy for deeper studies in clinical trials.
Authors: M Castro-Gago; I N Rodriguez; A Rodriguez-Núñez; J P Guitián; S L Rocamonde; S Rodriguez-Segade Journal: Childs Nerv Syst Date: 1989-12 Impact factor: 1.475
Authors: Daniela Pretti da Cunha Tirapelli; Luiza da Silva Lopes; João José Lachat; Benedicto Oscar Colli; Luís Fernando Tirapelli Journal: Arq Neuropsiquiatr Date: 2007-12 Impact factor: 1.420
Authors: Carlos Henrique Rocha Catalão; Glaucia Yuri Shimizu; Jacqueline Atsuko Tida; Camila Araújo Bernardino Garcia; Antonio Carlos Dos Santos; Carlos Ernesto Garrido Salmon; Maria José Alves Rocha; Luiza da Silva Lopes Journal: Childs Nerv Syst Date: 2017-04-05 Impact factor: 1.475
Authors: Elizabeth A Mazzio; David Bauer; Patricia Mendonca; Equar Taka; Karam F A Soliman Journal: J Neuroimmunol Date: 2016-12-01 Impact factor: 3.478